Differentiation between irritable bowel syndrome from inflammatory bowel disease flare-up through gut microbiota assessing test in quiescent IBD patients with IBS-like symptoms
dc.contributor
dc.contributor.author
dc.contributor.other
dc.date.accessioned
2020-10-08T09:53:22Z
dc.date.available
2020-10-08T09:53:22Z
dc.date.issued
2020-01
dc.identifier.uri
dc.description.abstract
Background
IBD is a chronic relapsing disorder and represent a huge burden in the life of the
individuals suffering from it. Moreover, once achieved the remission state, known as
quiescent IBD, around one third of the patients will still present intestinal symptoms
compatible with IBS (IBS-like symptoms). Even if both entities are well-defined and
differentiate, in quiescent IBD patients with persistent clinic the diagnosis is not easy
established through anamnesis and examination alone, and in most cases a
colonoscopy is performed in order to confirm the origin of the symptoms. Therefore,
there is a need for a non-invasive diagnostic test to differentiate between both entities
without the performance of unnecessary colonoscopies. RAID-Dx is a new diagnostic
tool based on the detection of the alteration on the main gut microbiota populations
related to IBS and IBD from a stool sample. As IBS and IBD both have its own
microbiological signature, this test has emerged as a potential, and inexpensive,
alternative to colonoscopy in the assessment of IBS-like symptoms in patients with
quiescent IBD.
Objectives
The main purpose of the study is to verify RAID-Dx test as an optimal diagnostic tool for
the differentiation of IBS and IBD flare-up in patients with quiescent IBD suffering from
IBS-like symptoms. For that reason, sensibility, specificity, PPV, PNV and likelihood-
ratios will need to be established. Secondary objectives include the assessment of diet
as an interaction factor of RAID-Dx results and the calculation of IBS prevalence in qIBD
patients.
Design and Methods
This is a cross-sectional study performed in 6 different centres located in Girona,
Figueres and Olot sanitary areas. The number of participants needed to recruit is 207
patients, from March to September 2020, and the sampling obtention follows a non-
probabilistic consecutive design method. Bivariate analyses have been used to
investigate potential associations between RAID-Dx results and various demographic,
disease factors and diet habits
dc.format.mimetype
application/pdf
dc.language.iso
eng
dc.relation.ispartofseries
Medicina (TFG)
dc.rights
Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.uri
dc.subject
dc.title
Differentiation between irritable bowel syndrome from inflammatory bowel disease flare-up through gut microbiota assessing test in quiescent IBD patients with IBS-like symptoms
dc.type
info:eu-repo/semantics/bachelorThesis
dc.rights.accessRights
info:eu-repo/semantics/openAccess
dc.audience.educationlevel
Estudis de grau